Dr. Joshi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1365 Clifton Road, NE
Building B, Suite 1400
Atlanta, GA 30322Phone+1 404-778-4898
Summary
- My clinical interests include the management of complex urologic malignancies, with particular specialization in open, laparoscopic, and robotic approaches to prostate, bladder, and kidney cancers, as well as the surgical management of other urologic cancers.
Education & Training
- Temple University School of Public HealthMPH, Health Policy and Management, 2017 - 2019
- Fox Chase Cancer CenterFellowship, Urologic Surgical Oncology, 2016 - 2018
- Vanderbilt University Medical CenterResidency, Urology, 2011 - 2016
- Vanderbilt University Medical CenterInternship, Transitional Year, 2011 - 2012
- Indiana University School of MedicineClass of 2011
- Indiana UniversityBA, Biology, Political Science, 2004 - 2007
Certifications & Licensure
- GA State Medical License 2019 - 2027
- PA State Medical License 2015 - 2021
- American Board of Urology Urology
Publications & Presentations
PubMed
- Molecular Subtyping for Predicting Pathological Upstaging and Survival Outcomes in Clinically Organ-confined Bladder Cancer Patients Undergoing Radical Cystectomy.Joep J de Jong, James A Proudfoot, Siamak Daneshmand, Robert S Svatek, Vikram Narayan
European Urology Open Science. 2025-03-01 - Characteristics, Treatment, and Outcomes of Primary Urethral Cancer: A Multicenter Review Over Two Decades.Benjamin D Hopkins, David C Qian, Karen M Xu, Ashley McCook-Veal, Jeffrey Switchenko
Clinical Genitourinary Cancer. 2025-02-01 - Trop-2 and Ephrin B2 expression in urothelial carcinoma with divergent differentiation and aggressive urothelial carcinoma subtypes.Katherine B Case, Dylan J Martini, Melad N Dababneh, Samuel Bidot, Bassel Nazha
American Journal of Clinical Pathology. 2024-12-20
Press Mentions
- Immune Cell Find Boosts Cancer Immunotherapy HopesOctober 26th, 2024
- Immune Cell Discovery Offers New Potential for Cancer ImmunotherapyOctober 25th, 2024
Committees
- Director, Bladder Cancer Program, Emory University Department of Urology 2020 - Present
Professional Memberships
- American Urological AssociationMember
- Society of Urologic OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: